UCSD New Depression Study (Los Angeles and San Diego area)

Are you one of the millions of Americans suffering from depression?

You may qualify for a research study in your area evaluating a non-invasive investigational device for the treatment of depression. This is a non-medication study.

NEST (Neosync EEG Synchronized TMS) is a new, non-invasive product that is being studied for the treatment of Major Depressive Disorder (MDD). It is an outpatient procedure that incorporates a new technology called sTMS (synchronized transcranial magnetic stimulation).

Research has shown that the neuronal activity in the brains of people with MDD is overly rhythmic resulting in low energy in the areas directly associated with depressive symptoms. NEST is based on the theory that the brain is a resonant system and can be “tuned” using low energy, sinusoidal (shaped like a sine curve) magnetic fields synchronized with each patient’s brain waves. It is believed that this will restore normal brain rhythm, function and energy, relieving or eliminating the depressive symptoms.

NEST is completely non-invasive. As shown in the picture below, the patient lies comfortably, the NEST treatment arm is lowered against the patient’s head, and therapy is delivered for approximately 30 minutes.

In order to qualify you must at least:

  • Be between 22 and 65 years of age
  • Have a diagnosis of Major Depressive Disorder (MDD)
Qualified participants in the study may receive:
  • All study-related care and treatment at no cost
  • Reimbursement for travel

subject with caution statement
You do not need health insurance to participate.

To contact a participating doctor in your area and to see if you qualify, please call or visit one of the available locations below:
Los Angeles, CA
UCLA Depression Research Program

San Diego, CA
UC San Diego Healthcare System